Skip to content
Riskpilot
← Back to search
Sign in
Sign in
Get full access
IBE Pharm AB
AB
Active
Org 5595263087
Älvgatan 40, 942 34
Älvsbyn
Retail sale of pharmaceutical products
·
NACE 4773
Est. 2025 · 1 year old
0 employees
Monitor
Share
Sweden
/
Companies
/
Retail sale of pharmaceutical products
/
IBE Pharm AB
Overview
Financials
People & ownership
Related companies
Loading company…
Financials
Revenue
SEK millions
0M
0M
0M
-1M
-1M
2025: 0M
0M
2025
EBITDA
SEK millions
0M
0M
0M
-1M
-1M
2025: 0M
0M
2025
Income statement
SEK thousands
Item
2025
Revenue
264
Staff expenses
−168
EBITDA
69
Depreciation & amort.
—
EBIT
69
Net financials
−0
Profit before tax
69
Tax
−14
Net profit
55
Balance sheet
SEK thousands
Item
2025
Total assets
280
Equity
80
Long-term debt
16
Short-term debt
185
Total debt
201
Financial ratios
5-year trend
EBITDA margin
26,1 %
This company
15,8 %
Market median
This company
Market median
65% above market
2025
2025
Equity ratio
28,5 %
This company
38,2 %
Market median
This company
Market median
25% below market
2025
2025
Return on equity
68,7 %
This company
18,4 %
Market median
This company
Market median
273% above market
2025
2025
Net profit margin
20,8 %
This company
8,1 %
Market median
This company
Market median
157% above market
2025
2025
Asset turnover
0,94×
This company
1,12×
Market median
This company
Market median
16% below market
2025
2025
Debt / equity
2,51×
This company
0,62×
Market median
This company
Market median
305% above market
2025
2025
Annual reports & filings
Annual report 2025
Filed via Bolagsverket / SCB · Period 2025-04-04 – 2025-12-31
View
PDF
More on IBE Pharm AB
Overview →
Headline figures, risk assessment and company summary
People & ownership →
Management, board and shareholder breakdown
Related companies →
Corporate hierarchy, parent and subsidiary network
